Qiagen, Eli Lilly Enter CDx Deal
February 14, 2013
Qiagen, Eli Lilly Enter CDx Deal
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Qiagen, Bayer Partner on Cancer Companion Dx
October 25, 2012 / GenomeWeb Daily News - FDA Clears Qiagen KRAS Test as CDx for Erbitux
July 9, 2012 / GenomeWeb Daily News - Qiagen, Eli Lilly Ink Companion Dx Deal for JAK2 Inhibitor
September 6, 2011 / GenomeWeb Daily News - Lab21, IntegraGen Co-developing CDx for Colorectal Cancer Therapy
February 22, 2013 / GenomeWeb Daily News - Dx Focus: Clarient to Offer Qiagen Therascreen KRAS Test as Erbitux CDx
January 31, 2013 / PCR Insider